Bicocca Open Archive

Logo unimib boa
CHIORAZZI, ALESSIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.426
EU - Europa 5.628
AS - Asia 1.905
OC - Oceania 27
Continente sconosciuto - Info sul continente non disponibili 23
SA - Sud America 14
AF - Africa 9
Totale 18.032
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.228
DE - Germania 1.227
IT - Italia 1.151
CN - Cina 1.117
SE - Svezia 926
IE - Irlanda 810
UA - Ucraina 518
GB - Regno Unito 305
HK - Hong Kong 304
CA - Canada 194
VN - Vietnam 194
AT - Austria 138
FI - Finlandia 123
RU - Federazione Russa 114
DK - Danimarca 113
FR - Francia 99
IN - India 78
JP - Giappone 47
TR - Turchia 45
SG - Singapore 39
BE - Belgio 34
KR - Corea 31
NL - Olanda 26
EU - Europa 23
MY - Malesia 20
NZ - Nuova Zelanda 17
IR - Iran 16
AU - Australia 10
BR - Brasile 9
PL - Polonia 7
EG - Egitto 6
ES - Italia 6
HR - Croazia 6
TW - Taiwan 6
CH - Svizzera 5
BG - Bulgaria 4
HU - Ungheria 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
MX - Messico 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
CZ - Repubblica Ceca 2
LB - Libano 2
RS - Serbia 2
SC - Seychelles 2
AR - Argentina 1
CR - Costa Rica 1
EE - Estonia 1
NO - Norvegia 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 18.032
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.859
Dublin 789
Woodbridge 773
Chandler 772
Frankfurt am Main 738
Wilmington 634
Houston 576
Fairfield 565
Dearborn 547
Jacksonville 538
Milan 448
Ashburn 387
New York 370
Princeton 302
Hong Kong 272
Seattle 231
Nanjing 229
Cambridge 160
Vienna 138
Shanghai 113
Beijing 96
Dong Ket 92
Lachine 85
Boardman 84
Guangzhou 84
Lawrence 78
Altamura 73
Nanchang 72
Shenyang 69
Andover 51
Falls Church 43
Hangzhou 41
Toronto 41
Jinan 38
Ottawa 37
San Diego 37
Fremont 36
Jiaxing 35
Kunming 34
Pune 34
Carate Brianza 33
Brussels 32
Tianjin 30
Changsha 29
Hebei 29
Zhengzhou 28
Helsinki 27
Nürnberg 27
Grafing 26
Norwalk 26
Los Angeles 25
Sacramento 24
Bergamo 22
Rome 22
Shangdi 22
Mountain View 20
Ningbo 20
London 19
Edmonton 18
Taizhou 17
Leawood 16
Codroipo 15
Hefei 15
Lissone 15
Philadelphia 15
Phoenix 15
Tokyo 15
Chicago 14
Mainz 13
Pasir Mas 12
Shinjuku 12
Kiev 11
Daejeon 10
Florence 10
Paris 10
Sesto San Giovanni 10
Wuhan 10
Washington 9
Bologna 8
Catania 8
Huizen 8
Cagliari 7
Desio 7
Fuzhou 7
San Mateo 7
Yongin-si 7
Auckland 6
Changchun 6
Frederick 6
Haikou 6
Lanzhou 6
Lappeenranta 6
Omegna 6
Palermo 6
Cassano Magnago 5
Chengdu 5
Kocaeli 5
Laurel 5
Menlo Park 5
Merate 5
Totale 13.461
Salva come PNG Salva come JPEG
Nome #
Age-related changes in the function and structure of the peripheral sensory pathway in mice 286
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 276
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 273
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 257
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 253
Artificial apolipoprotein corona enables nanoparticle brain targeting 251
An integrative approach to cisplatin chronic toxicities in mice reveals importance of organic cation-transporter-dependent protein networks for renoprotection 246
Executive control in schizophrenia: a preliminary study on the moderating role of COMT Val158Met for comorbid alcohol and substance use disorders 235
Studio della neurotossicità periferica indotta da farmaci antitubulinici in modelli sperimentali in vitro e in vivo 224
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 222
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 220
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 207
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 201
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 190
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 188
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 185
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 178
Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors 174
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 172
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 170
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 169
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 169
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 166
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 164
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 164
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 164
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 162
Tubulin: a target for antineoplastic drugs into the cancer cells but also in the peripheral nervous system 161
Study of perpheral neurotoxicity of different doses of oxaliplatin in cd1 mice 161
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 161
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 157
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 157
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: An in vitro study 154
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 153
Facial emotion recognition in schizophrenia: An exploratory study on the role of comorbid alcohol and substance use disorders and COMT Val158Met 153
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 152
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 151
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 150
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 150
MSCs ameliorate clinical course in rats with experimental autoimmune encephalomyelitis 147
Oxidative stress and inflammation induced by acute and subacute ultrafine exposure: contrinbution to alzheimer's disease 147
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 146
Lipoplatin tm: a less neurotoxic formulation of cisplatin 144
Current view in platinum drug mechanisms of peripheral neurotoxicity 144
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 144
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 143
OCT2 transporter involvement in development of cisplatin toxicity 143
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 142
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 140
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 139
Characterization in vivo of two different molecular mechanisms involved in the development of bortezomib-induced peripheral neuropathy 138
Multiple Neuroprotective Mechanisms of Mesenchymal Stem Cells 135
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 134
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 134
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 134
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 134
Granulocytes in actively induced Lewis rat EAE 133
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 131
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 130
Topiramate possible double efficacy profile: Oxaliplatin-induced peripheral neurotoxicity prevention and anticancer synergic action 130
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 129
Topiramate Prevents Oxaliplatin Neurotoxicity in a rat model 123
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 122
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 119
Epothilone B-induced toxic effects on peripheral nervous system: in vitro and in vivo experimental models 118
Multimodal experimental approach to the study of human neurological diseases 118
Morphology meets function to unravel Oxaliplatin Induced Peripheral Neurotoxicity (OIPN) 118
Effectiveness of MSC therapeutic administration on rats affected by chronic Experimental Autoimmune Encephalomyelitis 117
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 116
Evaluation of microtubule polimerization involved in the development of bortezomib-induced peripheral neuropathy through new in vitro and in vivo models 115
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 115
Tackling Oxaliplatin Induced Peripheral neurotoxicity: from bed to bench side and back. 115
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 114
MSCs effect on Dark Agouti rats affected by chronic EAE 113
Positive effect of Mesenchymal Stem Cells therapeutic administration on chronic Experimental Autoimmune Encephalomyelitis 112
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 112
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 112
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 111
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 110
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 110
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 109
NERVE EXCITABILITY TESTING AS THE LINK BETWEEN ANATOMY AND PHYSIOLOGY: AXONAL EXCITABILITY TESTING TO TEST IN VIVO MECHANISMS OF PERIPHERAL NERVE DAMAGE. 109
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 107
Ghrelin agonist HM01 attenuates chemotherapy-induced neurotoxicity in rodent models 107
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 107
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 106
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 106
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 104
Characterization of Glutamate Transporters in Peripheral Nervous System. 104
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 104
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 103
Genetic factors influencing the development of vincristine-induced neurotoxicity 103
Characterization of proteasome inhibition and tubulin stabilization in an in vivo rat model of bortezomib-induced peripheral neuropathy 102
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 102
OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity 102
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 101
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 101
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 101
Peripheral neurotoxicity induced by cisplatin: a possible role of OCT2 gene 101
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 101
Totale 14.737
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.252
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019808 0 0 0 0 0 0 0 0 0 215 225 368
2019/20203.675 432 226 226 202 338 455 593 248 334 319 247 55
2020/20213.424 147 132 377 353 262 306 408 321 290 258 204 366
2021/20221.946 152 234 171 177 139 181 95 106 82 143 134 332
2022/20233.484 389 846 380 332 259 540 63 181 277 51 104 62
2023/20242.435 97 98 101 146 386 725 508 163 158 53 0 0
Totale 19.369